Join to View Full Profile
1250 E Marshall St# InternalRichmond, VA 23298
Phone+1 804-828-0450
Fax+1 804-828-7591
Dr. Ginder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Gordon Ginder, MD, an oncologist based in Richmond, VA, has an extensive background in hematology and medical oncology with a fellowship completed at the University of Iowa Hospitals and Clinics. He earned his medical degree from Johns Hopkins University School of Medicine, followed by a residency in internal medicine at Case Western Reserve University and a post-doctoral fellowship at the National Institutes of Health. Dr. Ginder has professorial experience at the University of Minnesota Medical School and research expertise in amyloidosis, non-Hodgkin lymphoma, and other hematologic conditions. His published research has contributed to the understanding of protein interactions and cancer therapy. He has been recognized as a member of both the AAP and The American Society for Clinical Investigation.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1979 - 1980
Laboratory of Molecular Biology, National Institutes of HealthPost-Doctoral Fellowship, 1977 - 1979
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1975 - 1977
Johns Hopkins University School of MedicineClass of 1975
Certifications & Licensure
VA State Medical License 1998 - 2026
MN State Medical License 1991 - 1999
IA State Medical License 1979 - 1991
MD State Medical License 1977 - 1984
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member AAP, 2000
- Elected Member The American Society for Clinical Investigation, 1991
Publications & Presentations
PubMed
- DNA methylation matters: methylation of the γ-globin (HBG) gene promoters is required for postnatal silencing of HbF.Gordon D Ginder, Shengzhe Shang, David C Williams Jr
Blood. 2026-01-26 - The role of multivalency in the association of the eight twenty-one protein 2 (ETO2) with the nucleosome remodeling and deacetylase (NuRD) complex.Glory Dan-Dukor, Shengzhe Shang, Gage O Leighton, Christopher R Travis, Timothy D Schwochert
Nucleic Acids Research. 2025-05-22 - 5 citationsSrc inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia.Xiaoyan Hu, Lin Li, Jewel Nkwocha, Maciej Kmieciak, Shengzhe Shang
Signal Transduction and Targeted Therapy. 2025-02-10
Press Mentions
Combination Treatment Strategy Dramatically Increases Cell Death in LeukemiaFebruary 27th, 2025- VCU Secures $9 Million Grant to Establish Cancer Control Equity Research Center in VirginiaDecember 16th, 2024
- Rural Cancer Patients Undergo Less Radiation Treatment and Experience Poorer OutcomesAugust 17th, 2022
Grant Support
- The Role of the MBD2-NuRD Complex in Gamma-Globin Gene SilencingVIRGINIA COMMONWEALTH UNIVERSITY2018–2029
- Cancer Center Support GrantNational Cancer Institute1997–2017
- Postdoctoral Training Program In Cancer BiologyNational Cancer Institute2000–2011
- Protocol-Specific Research SupportNational Cancer Institute2008–2010
- Developmental FundsNational Cancer Institute2008–2010
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
